Krebs Biochemicals & Industries has informed that the meeting of the Board of Directors of the Company is scheduled on 25/03/2019, to consider and approve the allotment of shares pursuant to basis of allotment approved by the designated stock exchange.
The above information is a part of company’s filings submitted to BSE.